CME Group Inc. (CME) Stock Analysis
Breakout setup
Financial Services · Financial Data & Stock Exchanges
Hold if already holding. Not a fresh buy at $300.37, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Expensive valuation.
CME Group operates the world's largest derivatives exchange complex (CME, CBOT, NYMEX, COMEX) covering interest rates, equity indexes, FX, agricultural commodities, energy, metals, and crypto, plus a central counterparty clearing house and cash markets (BrokerTec, EBS). Record... Read more
Hold if already holding. Not a fresh buy at $300.37, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Expensive valuation. Chart setup: Golden cross, above all MAs, RSI 68, MACD bullish. Maintain position. Not compelling to add more. Score 5.7/10, moderate confidence.
Passes 7/8 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity 63d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: moderate.
Recent Developments — CME Group Inc.
Latest news
- CME Group (NASDAQ:CME) Shares Gap Down - What's Next? - MarketBeat — MarketBeat negative
- Raymond James reiterates CME Group stock rating citing volatility - Investing.com — Investing.com neutral
- Earnings call transcript: CME Group Q1 2026 beats expectations but stock dips - Investing.com — Investing.com positive
- CME Group is the most oversold financial stock as Q1 earnings roll on - MSN — MSN negative
- CME Stock Under Pressure After Double Miss - Benzinga — Benzinga negative
Generated 2026-05-20T21:06:21Z.
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- LOWCustomerone clearing firm12%10-K Item 1: 'One firm represented 12% of our clearing and transaction fees revenue for 2025.'
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
2 floor-breakers·1 ceiling hit
Priced at a premium — multiples above sector norms. Needs delivery on growth + margins to justify.static
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $300.37, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Expensive valuation. Chart setup: Golden cross, above all MAs, RSI 68, MACD bullish. Maintain position. Not compelling to add more. Target $301.85 (+0.5%), stop $290.85 (−3.3%), A.R:R -0.9:1. Score 5.7/10, moderate confidence.
Take-profit target: $301.85 (-0.2% upside). Target $301.85 (+0.5%), stop $290.85 (−3.3%), A.R:R -0.9:1. Stop-loss: $290.85.
Analyst target reached - limited upside remaining; Expensive valuation.
CME Group Inc. trades at a P/E of 26.0 (forward 23.7). TrendMatrix value score: 3.1/10. Verdict: Hold.
21 analysts cover CME with a consensus score of 3.4/5. Average price target: $307.
What does CME Group Inc. do?CME Group operates the world's largest derivatives exchange complex (CME, CBOT, NYMEX, COMEX) covering interest rates,...
CME Group operates the world's largest derivatives exchange complex (CME, CBOT, NYMEX, COMEX) covering interest rates, equity indexes, FX, agricultural commodities, energy, metals, and crypto, plus a central counterparty clearing house and cash markets (BrokerTec, EBS). Record ADV of 28.1 million contracts in 2025, with 85% of contract volume from member trades.